Dogru M, Okada N, Asano-Kato N, Igarashi A, Fukagawa K, Shimazaki J, Tsubota K, Fujishima H
Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Japan.
Clin Exp Allergy. 2006 Dec;36(12):1556-65. doi: 10.1111/j.1365-2222.2006.02581.x.
An increased understanding of the ocular surface alterations at the cellular level in the conjunctiva and the cornea, may help explain the pathogenesis and the subsequent clinical appearance of atopic ocular allergies, which may be potentially blinding.
To investigate MUC 1, 2 and 4 alterations, tear function and the ocular surface disorder in patients with atopic keratoconjunctivitis.
Twenty-eight eyes of 14 atopic keratoconjunctivitis patients as well as 22 eyes of 11 age-and sex-matched normal subjects were studied. The subjects underwent corneal sensitivity measurements, Schirmer's test, tear film break-up time (BUT), fluorescein and Rose Bengal staining of the ocular surface, conjunctival impression cytology and brush cytology. Impression cytology samples underwent periodic acid-Schiff and immunohistochemical staining with MUC 1, 2 and 4 antibodies. Brush cytology specimens underwent evaluation for inflammatory cell numbers and quantitative real-time-PCR for MUC 1, 2 and 4 mRNA expression. Patient eyes with fluorescein and Rose Bengal scores greater than four points were regarded to have significant epithelial disease in this study.
The mean corneal sensitivity and BUT values were significantly lower in atopic patients with significant epithelial disease, compared with patients with insignificant epithelial disease and controls (P < 0.01). Brush cytology specimens from patients with significant epithelial disease revealed significantly higher numbers of inflammatory cells (P < 0.01). Specimens from patient eyes showed positive staining for MUC 1, 2 and 4. MUC 1, 2 and 4 mRNA expressions were significantly higher in eyes with significant epithelial disease compared with eyes with insignificant epithelial disease and eyes of control subjects.
Ocular surface inflammation, decline in corneal sensitivity, tear film instability, changes in conjunctival epithelial MUC 1, 2 and 4 mRNA expressions were thought to be important in the pathogenesis of atopic ocular surface disease.
在细胞水平上加深对结膜和角膜眼表改变的理解,可能有助于解释特应性眼部过敏的发病机制及随后的临床表现,特应性眼部过敏可能会导致失明。
研究特应性角结膜炎患者的MUC 1、2和4改变、泪液功能及眼表疾病。
对14例特应性角结膜炎患者的28只眼以及11名年龄和性别匹配的正常受试者的22只眼进行研究。受试者接受角膜敏感性测量、泪液分泌试验、泪膜破裂时间(BUT)、眼表荧光素和孟加拉玫瑰红染色、结膜印片细胞学检查和刷片细胞学检查。印片细胞学样本进行过碘酸-希夫染色及用MUC 1、2和4抗体进行免疫组织化学染色。刷片细胞学标本进行炎性细胞数量评估及MUC 1、2和4 mRNA表达的定量实时聚合酶链反应。在本研究中,荧光素和孟加拉玫瑰红评分大于4分的患者眼被视为患有明显的上皮疾病。
与上皮疾病不明显的患者及对照组相比,患有明显上皮疾病的特应性患者的平均角膜敏感性和BUT值显著更低(P < 0.01)。患有明显上皮疾病的患者的刷片细胞学标本显示炎性细胞数量显著更多(P < 0.01)。患者眼的标本显示MUC 1、2和4呈阳性染色。与上皮疾病不明显的眼及对照组的眼相比,患有明显上皮疾病的眼中MUC 1、2和4 mRNA表达显著更高。
眼表炎症、角膜敏感性下降、泪膜不稳定、结膜上皮MUC 1、2和4 mRNA表达的变化被认为在特应性眼表疾病的发病机制中起重要作用。